Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
17,194,910
-
Total 13F shares
-
2,360,259
-
Share change
-
+543,874
-
Total reported value
-
$13,310,203
-
Price per share
-
$5.64
-
Number of holders
-
35
-
Value change
-
+$3,384,570
-
Number of buys
-
19
-
Number of sells
-
16
Institutional Holders of Journey Medical Corp - Common Stock (DERM) as of Q2 2024
As of 30 Jun 2024,
Journey Medical Corp - Common Stock (DERM) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,360,259 shares.
The largest 10 holders included
VANGUARD GROUP INC, Cambridge Investment Research Advisors, Inc., RENAISSANCE TECHNOLOGIES LLC, AMERICAN FINANCIAL GROUP INC, PVG ASSET MANAGEMENT CORP, TANG CAPITAL MANAGEMENT LLC, ENVESTNET ASSET MANAGEMENT INC, Rosalind Advisors, Inc., GEODE CAPITAL MANAGEMENT, LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.